7 unchanged sentences
We did not sell any unregistered shares of common stock during the fiscal year ended June 30, 2026.
−Removed: In July 2024, we issued an aggregate of $350.0 million principal amount of 2.25% convertible senior notes due in August 2029.
+Added: In November 2025, we issued an aggregate of $575.0 million principal amount of 0.5% convertible senior notes due in February 2031.
The 2031 Notes were issued to the initial purchasers in reliance upon Section 4(a)(2) of the Securities Act in transactions not involving any public offering.
2 unchanged sentences
Initially, a maximum of 1,625,122 shares of our common stock may be issued upon conversion of the 2031 Notes based on the initial maximum conversion rate of 2.8263 shares of common stock per $1,000 principal amount of 2031 Notes which is subject to customary anti-dilution adjustment provisions.
+Added: The 2031 Notes are convertible into a combination of cash and shares of our common stock, at an initial conversion rate of 2.8263 shares of common stock per $1,000 principal amount of 2031 Notes, which is equivalent to an initial conversion price of approximately $353.82 per share of our common stock.
+Added: The default settlement method is a combination settlement with a specified dollar amount of $1,000 per $1,000 principal amount of notes.
+Added: The conversion rate is subject to customary adjustments for certain dilutive events.
Issuer Purchases of Equity Securities
−Removed: Excluding shares tendered to satisfy minimum statutory withholding obligations related to the vesting of RSUs, we repurchased 531,314 shares of common stock during the first quarter of fiscal year 2025.
−Removed: We did not repurchase any shares of common stock during the ensuing quarters in fiscal year 2025.
+Added: Excluding shares tendered to satisfy minimum statutory withholding obligations related to the vesting of RSUs, we repurchased 1,111,825 shares of common stock during fiscal year 2026 for $271.9 million.
+Added: These repurchases included 546,945 shares acquired during the second fiscal quarter at an average price of $267.03 per share and 564,880 shares acquired during the fourth fiscal quarter at an average price of $218.82 per share.
As of June 30, 2026, the maximum number of shares of common stock that may yet be purchased under the current plan authorized by the Board of Directors is 78,731.
+Added: The following table contains information about the shares of common stock we purchased during the quarter ended June 30, 2026:
+Added: Maximum number (or
+Added: approximate dollar
+Added: Total number of
+Added: shares (or units)
+Added: Total number of
+Added: Average price
+Added: part of publicly
+Added: yet be purchased
+Added: shares (or units)
+Added: paid per share (or
+Added: announced plans or
+Added: under the plans or
+Added: April 1 to April 30, 2026
+Added: May 1 to May 31, 2026
+Added: June 1 to June 30, 2026
+Added: In September 2022, when there were 1,131,301 shares remaining authorized to repurchase under the then-existing share repurchase program, the Board of Directors renewed the authorization and revised the maximum number of shares to 2,000,000 shares authorized under the stock repurchase program.
+Added: Upon repurchase, shares of common stock are restored to the status of authorized but unissued shares, and we record them as a reduction in the number of shares of common stock issued and outstanding in our consolidated financial statements.
Securities Authorized for Issuance Under Equity Compensation Plans
21 unchanged sentences
The graph below compares the cumulative total stockholder return for the period beginning on the market close on the last trading day before the beginning of our fifth preceding fiscal year through and including the end of our last completed fiscal year with (a) The Nasdaq Composite Index and (b) a peer group of publicly traded issuer(s) with which we have generally competed.
−Removed: The peer group includes the following companies:
+Added: The old peer group includes the following companies:
Conmed Corp, Leidos Holdings Inc.
and Smiths Group plc.
−Removed: The graph assumes that $100.00 was invested on June 30, 2020 in (a) our common stock, (b) The Nasdaq Composite Index, and (c) the companies comprising the peer group described above (weighted according to the issuer’s stock market capitalization at the beginning of each period for which a return is indicated).
+Added: The new peer group includes the following companies:
+Added: Conmed Corp, Leidos Holdings Inc.
+Added: and Evolv Technologies Holdings, Inc., but excludes Smiths Group Plc which is in the process of divesting Smiths Detection.
+Added: Because of this pending divestiture, we believe that Evolv Technologies Holdings, Inc.
+Added: more closely reflects our Company's participation in the security screening and detection market.
+Added: The graph assumes that $100.00 was invested on June 30, 2021 in (a) our common stock, (b) The Nasdaq Composite Index, and (c) the companies comprising the old and new peer group described above (weighted according to the issuer’s stock market capitalization at the beginning of each period for which a return is indicated).
The graph assumes that all dividends were reinvested.
4 unchanged sentences
The Nasdaq Composite Index
+Added: Old Peer Group
+Added: New Peer Group
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.